1XVN
echinomycin (ACGTACGT)2 complex
Summary for 1XVN
Entry DOI | 10.2210/pdb1xvn/pdb |
Related | 185D 193D 1PFE 1VS2 1XVK 1XVR 2ADW 2DA8 3GO3 |
Related PRD ID | PRD_000491 |
Descriptor | 5'-D(*AP*CP*GP*TP*AP*CP*GP*T)-3', ECHINOMYCIN, MAGNESIUM ION, ... (5 entities in total) |
Functional Keywords | bisintercalator, hoogsteen basepair, depsipeptide, quinoxaline, thioacetal, antibiotic, antitumor, dna-antibiotic complex, dna/antibiotic |
Biological source | STREPTOMYCES ECHINATUS |
Total number of polymer chains | 2 |
Total formula weight | 3608.24 |
Authors | Cuesta-Seijo, J.A.,Sheldrick, G.M. (deposition date: 2004-10-28, release date: 2005-04-12, Last modification date: 2025-03-26) |
Primary citation | Cuesta-Seijo, J.A.,Sheldrick, G.M. Structures of Complexes between Echinomycin and Duplex DNA. Acta Crystallogr.,Sect.D, 61:442-, 2005 Cited by PubMed Abstract: The structure of the bis-intercalation complex of the depsipeptide antibiotic echinomycin with (CGTACG)2 has been redetermined at a higher resolution (1.4 A) and new high-resolution structures (1.1-1.5 A) are reported for the complexes of echinomycin with (GCGTACGC)2 (at both low and high ionic strengths) and (ACGTACGT)2. The structures show the expected Hoogsteen pairing for the base pairs flanking the intercalating chromophores on the outside and Watson-Crick pairing for both base pairs enclosed by the echinomycin. In the octamer complexes but not the hexamer complex, the echinomycin molecule, which would possess a molecular twofold axis were it not for the thioacetal bridge, shows twofold disorder. In all the structures the stacking of the base pairs and chromophores is extended by intermolecular stacking. The structures provide more precise details of the hydrogen bonding and other interactions between the bis-intercalating antibiotics and the duplex DNA than were previously available. PubMed: 15805599DOI: 10.1107/S090744490500137X PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.5 Å) |
Structure validation
Download full validation report
